Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
883.25
16.15 (1.86%)
BSENSE

Jun 18

BSE+NSE Vol: 9.84 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "883.25",
    "chg": 16.15,
    "chgp": "1.86%",
    "dir": 1,
    "prev_price": "867.10",
    "mcapval": "15,849.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE987B01026",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "9.84 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Q4 Results Outcome 1st June Highlights: IndiGo & NMDC Steel soar post Q4, IREDA, Inox Wind, Natco Pharma & Glenmark shares fall",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-01 15:44:05",
        "description": "Q4 Results Outcome 1st June Highlights: IndiGo & NMDC Steel soar post Q4, IREDA, Inox Wind, Natco Pharma & Glenmark shares fall  BusinessLine..."
      },
      {
        "title": "Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-01 11:45:20",
        "description": "Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?  Business Standard..."
      },
      {
        "title": "Q4 Results 29th May Live: IndiGo posts Q4 loss, RCOM loss widens, Natco Pharma & BEML Q4 profit down, Asian Paints & IPCA Lab profit up y-o-y, Glenmark Pharma, IREDA, Gujarat Gas, NMDC, JM Financial to announce Q4 results",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-29 18:30:59",
        "description": "Q4 Results 29th May Live: IndiGo posts Q4 loss, RCOM loss widens, Natco Pharma & BEML Q4 profit down, Asian Paints & IPCA Lab profit up y-o-y, Glenmark Pharma, IREDA, Gujarat Gas, NMDC, JM Financial to announce Q4 results  BusinessLine..."
      },
      {
        "title": "Natco Pharmas Q4 net down 34% at 269 cr",
        "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNlk4bjhqNUU5QWliU3RfWlRBSks0bGl3cGRnajNNU1NpY3dCaFdEbVRsWXB5bGpPX3FaQS1qZVFmSGM3N1dTSXZVNnF2Y3kyYmVKd0ZqcG5lQm01R2NISUdoWGtxTW1kaUEtWmxlVXotYlZKYmRDZVhySEFidkhZWE1zSGRBb3k2Ri1SRUIyaE5vVERNd2VvSWZTdnpJWjZmQ0FuS1AtOWfSAa8BQVVfeXFMTUFsMlo5MUx5eGNwWVRVdGN4TjVmYVZWSHFtQ1VmekFjRGhZRE5HNTdpbWhMbkd4cmhlZFNxMXQxdTg3Qm9aRXJjQUd2OVJsYkFIZU5mSnJaTzBXWDh6eFgtUFZVNE9lUlpIQkU4NVBTY19vd0NCdHpEaGlIUTBydW9DN1FHTGltdE5CN20xUmZzOTVrSnpqRXFVRDBXMmhkVWhtQVBxTnJUa0w0MFR3bw?oc=5",
        "imagepath": "",
        "date": "2026-05-29 16:51:32",
        "description": "Natco Pharmas Q4 net down 34% at 269 cr  BusinessLine..."
      },
      {
        "title": "Natco Pharma Ltd leads losers in \\'A\\' group",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-29 15:04:42",
        "description": "Natco Pharma Ltd leads losers in \\'A\\' group  Business Standard..."
      },
      {
        "title": "Natco Pharma shares slump 15% after Q4 results; here\\'s why the stock is falling",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-29 15:04:16",
        "description": "Natco Pharma shares slump 15% after Q4 results; here\\'s why the stock is falling  Business Today..."
      }
    ],
    "total": 6,
    "sid": "156274",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-Jun-2026",
      "details": "Earning call Transcript for the concall held on May 29 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "03-Jun-2026",
      "details": "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Newspaper Publication of Annual Audited Financial Results for the Quarter and Year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

04-Jun-2026 | Source : BSE

Earning call Transcript for the concall held on May 29 2026

Announcement under Regulation 30 (LODR)-Press Release / Media Release

03-Jun-2026 | Source : BSE

NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-May-2026 | Source : BSE

Newspaper Publication of Annual Audited Financial Results for the Quarter and Year ended March 31 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Natco Pharma Ltd. has declared 75% dividend, ex-date: 18 Feb 26

stock-summary
SPLITS

Natco Pharma Ltd. has announced 2:10 stock split, ex-date: 26 Nov 15

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available